Joanne Xu
Directeur/Membre du Conseil chez Exscientia AI Ltd.
Postes actifs de Joanne Xu
Sociétés | Poste | Début | Fin |
---|---|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 01/04/2021 | - |
Shanghai Yunfeng Investment Management Co. Ltd.
Shanghai Yunfeng Investment Management Co. Ltd. Investment ManagersFinance Shanghai Yunfeng Investment Management Co. Ltd (Yunfeng Capital) is a private equity firm founded in 2010 by Feng Yu and Yun Ma. The firm is headquartered in Shanghai, China. | Private Equity Investor | 01/05/2023 | - |
Historique de carrière de Joanne Xu
Anciens postes connus de Joanne Xu
Sociétés | Poste | Début | Fin |
---|---|---|---|
SBVA
SBVA Investment ManagersFinance SBVA (SBVA) is a private equity/venture capital subsidiary of SoftBank Korea Co., Ltd founded in 2000. The firm is headquartered in Seoul, South Korea. | Private Equity Investor | 01/01/2020 | 01/05/2023 |
EXSCIENTIA PLC | Directeur/Membre du Conseil | 01/04/2021 | 18/05/2022 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | 01/08/2008 | 01/01/2020 |
Integrated Clinical Oncology Network Pty Ltd.
Integrated Clinical Oncology Network Pty Ltd. Hospital/Nursing ManagementHealth Services Integrated Clinical Oncology Network Pty Ltd. engages in the provision of cancer and hematological care services. It offers chemotherapy compunding, pharmacy management, remote radiation therapy planning, and medical physics services. The firm also offers patients the option of emerging treatment through clinical trials. The company was founded by Stuart Giles in 2012 and is headquartered in South Brisbane, Australia. | Directeur/Membre du Conseil | - | - |
Formation de Joanne Xu
Nanjing University | Undergraduate Degree |
Waseda University | Graduate Degree |
Harvard Business School | Masters Business Admin |
Statistiques
Internationale
Royaume-Uni | 3 |
Chine | 3 |
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 3 |
Private Equity Investor | 2 |
Undergraduate Degree | 1 |
Sectorielle
Finance | 4 |
Consumer Services | 4 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
EXSCIENTIA PLC | Health Technology |
Entreprise privées | 5 |
---|---|
SBVA
SBVA Investment ManagersFinance SBVA (SBVA) is a private equity/venture capital subsidiary of SoftBank Korea Co., Ltd founded in 2000. The firm is headquartered in Seoul, South Korea. | Finance |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Integrated Clinical Oncology Network Pty Ltd.
Integrated Clinical Oncology Network Pty Ltd. Hospital/Nursing ManagementHealth Services Integrated Clinical Oncology Network Pty Ltd. engages in the provision of cancer and hematological care services. It offers chemotherapy compunding, pharmacy management, remote radiation therapy planning, and medical physics services. The firm also offers patients the option of emerging treatment through clinical trials. The company was founded by Stuart Giles in 2012 and is headquartered in South Brisbane, Australia. | Health Services |
Shanghai Yunfeng Investment Management Co. Ltd.
Shanghai Yunfeng Investment Management Co. Ltd. Investment ManagersFinance Shanghai Yunfeng Investment Management Co. Ltd (Yunfeng Capital) is a private equity firm founded in 2010 by Feng Yu and Yun Ma. The firm is headquartered in Shanghai, China. | Finance |